Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Short-Term Debt issuances (2020)

Pharma-Bio Serv's Short-Term Debt issuances history spans 1 years, with the latest figure at $1.9 million for Q2 2020.

  • For Q2 2020, Short-Term Debt issuances changed N/A year-over-year to $1.9 million; the TTM value through Apr 2021 reached $1.9 million, changed N/A, while the annual FY2020 figure was $1.9 million, N/A changed from the prior year.
  • Short-Term Debt issuances reached $1.9 million in Q2 2020 per PBSV's latest filing.
  • In the past five years, Short-Term Debt issuances ranged from a high of $1.9 million in Q2 2020 to a low of $1.9 million in Q2 2020.